THNR

THNR
About Amplify Weight Loss Drug & Treatment ETF
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
About Amplify Weight Loss Drug & Treatment ETF
THNR provides access to global companies expected to economically benefit from weight loss drug development. THNR seeks investment results that generally correspond to the performance (before fees and expenses) of the VettaFi Weight Loss Drug & Treatment Index.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
NVO | Novo Nordisk A/S | 13.32% | 9.28K | $524.80K |
LLY | Eli Lilly and Company | 12.91% | 459 | $508.61K |
REGN | Regeneron Pharmaceuticals, Inc. | 6.84% | 332 | $269.67K |
AMGN | Amgen Inc. | 6.79% | 783 | $267.50K |
MRK | Merck & Co., Inc. | 5.19% | 1.88K | $204.38K |
AZN | AstraZeneca PLC | 4.98% | 2.06K | $196.41K |
ABBV | AbbVie Inc. | 4.92% | 830 | $193.74K |
PFE | Pfizer Inc. | 4.64% | 7.24K | $182.90K |
ARWR | Arrowhead Pharmaceuticals, Inc. | 3.78% | 2.27K | $148.92K |
HIMS | Hims & Hers Health, Inc. | 3.31% | 3.68K | $130.46K |
VKTX | Viking Therapeutics, Inc. | 1.62% | 1.97K | $63.92K |
SRRK | Scholar Rock Holding Corporation | 1.60% | 1.43K | $63.03K |
HKD | AMTD Digital Inc. | - | 1 | - |
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
SECTOR HOLDINGS
Healthcare
Financial Services
Cash & OthersASSET ALLOCATION BY REGION
Holdings (Top 20)
NVO
Novo Nordisk A/S
LLY
Eli Lilly and Company
REGN
Regeneron Pharmaceuticals, Inc.
AMGN
Amgen Inc.
MRK
Merck & Co., Inc.
AZN
AstraZeneca PLC
ABBV
AbbVie Inc.
PFE
Pfizer Inc.
ARWR
Arrowhead Pharmaceuticals, Inc.
HIMS
Hims & Hers Health, Inc.
VKTX
Viking Therapeutics, Inc.
SRRK
Scholar Rock Holding Corporation
HKD
AMTD Digital Inc.
